ArticleWorld journal of gastrointestinal surgery2026
Assessing predictive value of contrast-enhanced ultrasound combined with doppler ultrasound for post-transcatheter arterial chemoembolization prognosis in hepatocellular carcinoma.
Article in World journal of gastrointestinal surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatocellular carcinoma (HCC) is a significant global health issue that is often diagnosed in advanced stages. Transcatheter arterial chemoembolization (TACE) is a standard intervention for unresectable HCC; however, it is frequently followed by tumor recurrence, highlighting the need for reliable prognostic tools. This study evaluated the combined predictive value of contrast-enhanced ultrasound (CEUS) and Doppler ultrasound in assessing the clinical outcomes post-TACE.
aimTo develop a comprehensive imaging strategy that can guide personalized treatment planning through an improved assessment of tumor vascularization and liver function, assess the predictive value of CEUS combined with Doppler ultrasound in patients with HCC who underwent TACE.
methodsThis retrospective study analyzed 124 patients with HCC who underwent TACE. Based on 1-year outcomes, the patients were stratified into good (
resultsSignificant differences were observed between the two groups in terms of TNM stage, number of lesions, tumor size, arrival time (AT), washout time (WT), hepatic artery peak systolic velocity (VPs), portal vein velocity, and blood flow grading (
conclusionThe combination of CEUS and Doppler ultrasound parameters, which reflect tumor vascularization and liver function, has high a predictive value for the prognosis of patients with HCC following TACE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.